• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

建立并验证预测冠状动脉慢血流风险的列线图。

Establishment and verification of a nomogram that predicts the risk for coronary slow flow.

机构信息

Department of Hyperbaric Oxygen, The First Medical Centre of Chinese People's Liberation Army (PLA) General Hospital, Beijing, China.

Graduate School, Chinese People's Liberation Army Medical School, Beijing, China.

出版信息

Front Endocrinol (Lausanne). 2024 Mar 4;15:1337284. doi: 10.3389/fendo.2024.1337284. eCollection 2024.

DOI:10.3389/fendo.2024.1337284
PMID:38501108
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10944880/
Abstract

BACKGROUND

Coronary slow flow (CSF) has gained significance as a chronic coronary artery disease, but few studies have integrated both biological and anatomical factors for CSF assessment. This study aimed to develop and validate a simple-to-use nomogram for predicting CSF risk by combining biological and anatomical factors.

METHODS

In this retrospective case-control study, 1042 patients (614 CSF cases and 428 controls) were randomly assigned to the development and validation cohorts at a 7:3 ratio. Potential predictive factors were identified using least absolute shrinkage and selection operator regression and subsequently utilized in multivariate logistic regression to construct the nomogram. Validation of the nomogram was assessed by discrimination and calibration.

RESULTS

N-terminal pro brain natriuretic peptide, high density lipoprotein cholesterol, hemoglobin, left anterior descending artery diameter, left circumflex artery diameter, and right coronary artery diameter were independent predictors of CSF. The model displayed high discrimination in the development and validation cohorts (C-index 0.771, 95% CI: 0.737-0.805 and 0.805, 95% CI: 0.757-0.853, respectively). The calibration curves for both cohorts showed close alignment between predicted and actual risk estimates, demonstrating improved model calibration. Decision curve analysis suggested high clinical utility for the predictive nomogram.

CONCLUSION

The constructed nomogram accurately and individually predicts the risk of CSF for patients with suspected CSF and may be considered for use in clinical care.

摘要

背景

冠状动脉慢血流(CSF)已成为慢性冠状动脉疾病的重要表现,但很少有研究综合考虑生物学和解剖学因素来评估 CSF。本研究旨在通过结合生物学和解剖学因素,开发并验证一种简单易用的 CSF 风险预测列线图。

方法

这是一项回顾性病例对照研究,1042 名患者(614 例 CSF 病例和 428 例对照)以 7:3 的比例随机分配到开发和验证队列中。使用最小绝对收缩和选择算子回归确定潜在的预测因素,然后将这些因素用于多变量逻辑回归中,构建列线图。通过判别和校准评估列线图的验证。

结果

N 末端脑利钠肽前体、高密度脂蛋白胆固醇、血红蛋白、左前降支直径、左旋支直径和右冠状动脉直径是 CSF 的独立预测因素。该模型在开发和验证队列中具有较高的判别能力(C 指数分别为 0.771(95%CI:0.737-0.805)和 0.805(95%CI:0.757-0.853))。两个队列的校准曲线均显示预测风险与实际风险估计之间的紧密一致性,表明模型校准得到改善。决策曲线分析表明,预测列线图具有较高的临床实用性。

结论

所构建的列线图可准确地个体化预测疑似 CSF 患者的 CSF 风险,可考虑用于临床护理。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b73/10944880/a27157396e93/fendo-15-1337284-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b73/10944880/06fef3773dc3/fendo-15-1337284-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b73/10944880/089fae7be11c/fendo-15-1337284-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b73/10944880/83538cb04e98/fendo-15-1337284-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b73/10944880/a27157396e93/fendo-15-1337284-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b73/10944880/06fef3773dc3/fendo-15-1337284-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b73/10944880/089fae7be11c/fendo-15-1337284-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b73/10944880/83538cb04e98/fendo-15-1337284-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b73/10944880/a27157396e93/fendo-15-1337284-g004.jpg

相似文献

1
Establishment and verification of a nomogram that predicts the risk for coronary slow flow.建立并验证预测冠状动脉慢血流风险的列线图。
Front Endocrinol (Lausanne). 2024 Mar 4;15:1337284. doi: 10.3389/fendo.2024.1337284. eCollection 2024.
2
Development and validation of a risk prediction nomogram for in-stent restenosis in patients undergoing percutaneous coronary intervention.经皮冠状动脉介入治疗患者支架内再狭窄风险预测列线图的建立与验证。
BMC Cardiovasc Disord. 2021 Sep 14;21(1):435. doi: 10.1186/s12872-021-02255-4.
3
Development and validation of a novel nomogram to predict chronic total occlusion before coronary angiography.一种用于在冠状动脉造影术前预测慢性完全闭塞的新型列线图的开发与验证
Eur Rev Med Pharmacol Sci. 2022 Nov;26(21):8011-8021. doi: 10.26355/eurrev_202211_30155.
4
A practical nomogram for predicting coronary thrombosis for Kawasaki disease patients with medium or large coronary artery aneurysm.用于预测伴有中等或大型冠状动脉瘤的川崎病患者冠状动脉血栓形成的实用列线图。
Clin Exp Med. 2023 Aug;23(4):1317-1324. doi: 10.1007/s10238-022-00893-2. Epub 2022 Sep 23.
5
Development and validation of a nomogram for predicting significant coronary artery stenosis in suspected non-ST-segment elevation acute coronary artery syndrome with low-to-intermediate risk stratification.用于预测疑似非ST段抬高型急性冠状动脉综合征且风险分层为低至中度的严重冠状动脉狭窄的列线图的开发与验证
Front Cardiovasc Med. 2022 Dec 19;9:1013563. doi: 10.3389/fcvm.2022.1013563. eCollection 2022.
6
Derivation and validation of a nomogram for predicting nonventilator hospital-acquired pneumonia among older hospitalized patients.用于预测老年住院患者非呼吸机相关性医院获得性肺炎的列线图的推导与验证
BMC Pulm Med. 2022 Apr 15;22(1):144. doi: 10.1186/s12890-022-01941-z.
7
Predicting long-term prognosis after percutaneous coronary intervention in patients with new onset ST-elevation myocardial infarction: development and external validation of a nomogram model.预测新发 ST 段抬高型心肌梗死患者经皮冠状动脉介入治疗后的长期预后:列线图模型的建立与外部验证。
Cardiovasc Diabetol. 2023 Apr 13;22(1):87. doi: 10.1186/s12933-023-01820-9.
8
Development and validation of a nomogram to predict in-hospital cardiac arrest among patients admitted with acute coronary syndrome.开发和验证一种列线图,用于预测因急性冠状动脉综合征入院的患者的院内心搏骤停。
Am J Emerg Med. 2021 Nov;49:240-248. doi: 10.1016/j.ajem.2021.05.082. Epub 2021 Jun 6.
9
A LASSO-derived developing and validating risk model for chronic total occlusion in Asian population before coronary angiography.一种基于套索算法得出的、用于在冠状动脉造影术前对亚洲人群慢性完全闭塞进行风险评估模型的开发与验证
Cardiovasc Diagn Ther. 2023 Jun 30;13(3):496-508. doi: 10.21037/cdt-22-466. Epub 2023 May 10.
10
Daily exercise improves the long-term prognosis of patients with acute coronary syndrome.日常锻炼可改善急性冠状动脉综合征患者的长期预后。
Front Public Health. 2023 Mar 15;11:1126413. doi: 10.3389/fpubh.2023.1126413. eCollection 2023.

本文引用的文献

1
Mechanisms of the "No-Reflow" Phenomenon After Acute Myocardial Infarction: Potential Role of Pericytes.急性心肌梗死后“无复流”现象的机制:周细胞的潜在作用
JACC Basic Transl Sci. 2022 Sep 21;8(2):204-220. doi: 10.1016/j.jacbts.2022.06.008. eCollection 2023 Feb.
2
Predictive value of thrombolysis in myocardial infarction frame count for coronary microvascular dysfunction evaluated with an angiography-derived index of microcirculatory resistance in patients with coronary slow flow.心肌梗死帧数溶栓对冠状动脉慢血流患者冠状动脉微血管功能障碍的预测价值:采用血管造影衍生的微循环阻力指数进行评估
Quant Imaging Med Surg. 2022 Oct;12(10):4942-4952. doi: 10.21037/qims-22-224.
3
Hidden Coronary Atherosclerosis Assessment but Not Coronary Flow Reserve Helps to Explain the Slow Coronary Flow Phenomenon in Patients with Angiographically Normal Coronary Arteries.
隐匿性冠状动脉粥样硬化评估而非冠状动脉血流储备有助于解释冠状动脉造影正常患者的慢血流现象。
Diagnostics (Basel). 2022 Sep 8;12(9):2173. doi: 10.3390/diagnostics12092173.
4
Slow Coronary Blood Flow: Pathogenesis and Clinical Implications.冠状动脉血流缓慢:发病机制与临床意义
Eur Cardiol. 2022 Mar 14;17:e08. doi: 10.15420/ecr.2021.46. eCollection 2022 Feb.
5
Evaluate the Correlation between the TIMI Frame Count, IMR, and CFR in Coronary Microvascular Disease.评估 TIMI 帧数、IMR 和 CFR 在冠状动脉微血管疾病中的相关性。
J Interv Cardiol. 2022 Feb 2;2022:6361398. doi: 10.1155/2022/6361398. eCollection 2022.
6
Inclusion of Smoking Data in Cardiovascular Disease Risk Estimation.将吸烟数据纳入心血管疾病风险评估。
JAMA Cardiol. 2022 Feb 1;7(2):195-203. doi: 10.1001/jamacardio.2021.4990.
7
The relationship between triglyceride/high-density lipoprotein cholesterol ratio and coronary slow-flow phenomenon.甘油三酯/高密度脂蛋白胆固醇比值与冠状动脉慢血流现象的关系。
Int J Cardiovasc Imaging. 2022 Jan;38(1):5-13. doi: 10.1007/s10554-021-02387-w. Epub 2021 Aug 28.
8
Slow Coronary Flow: Pathophysiology, Clinical Implications, and Therapeutic Management.缓慢性冠状动脉血流:病理生理学、临床意义和治疗管理。
Angiology. 2021 Oct;72(9):808-818. doi: 10.1177/00033197211004390. Epub 2021 Mar 29.
9
The fluid mechanics of poohsticks.噗噗棒的流体力学。
Philos Trans A Math Phys Eng Sci. 2020 Sep 4;378(2179):20190522. doi: 10.1098/rsta.2019.0522. Epub 2020 Aug 3.
10
NT-proBNP as a Cornerstone for Prognosis in Valve Disease: All We Need Is Blood.N末端B型利钠肽原作为瓣膜病预后的基石:我们所需的只是血液。
J Am Coll Cardiol. 2020 Apr 14;75(14):1673-1675. doi: 10.1016/j.jacc.2020.02.030.